Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BOTULINUM TOXIN TYPE A Cause Gait disturbance? 105 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Gait disturbance have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 2.8% of all adverse event reports for BOTULINUM TOXIN TYPE A.

105
Reports of Gait disturbance with BOTULINUM TOXIN TYPE A
2.8%
of all BOTULINUM TOXIN TYPE A reports
74
Deaths
94
Hospitalizations

How Dangerous Is Gait disturbance From BOTULINUM TOXIN TYPE A?

Of the 105 reports, 74 (70.5%) resulted in death, 94 (89.5%) required hospitalization, and 74 (70.5%) were considered life-threatening.

Is Gait disturbance Listed in the Official Label?

Yes, Gait disturbance is listed as a known adverse reaction in the official FDA drug label for BOTULINUM TOXIN TYPE A.

What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?

Off label use (1,785) Drug ineffective (1,175) Drug intolerance (1,004) Product use in unapproved indication (950) Headache (797) Migraine (775) Maternal exposure during pregnancy (716) Pain (714) Hypoaesthesia (703) Nausea (665)

What Other Drugs Cause Gait disturbance?

DALFAMPRIDINE (8,780) ADALIMUMAB (8,714) ETANERCEPT (6,505) METHOTREXATE (5,141) TOFACITINIB (3,878) PREGABALIN (3,590) DIMETHYL (3,434) SECUKINUMAB (3,222) ABATACEPT (3,110) LEFLUNOMIDE (3,041)

Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Gait disturbance Risk?

BOTULINUM TOXIN TYPE A vs BREMELANOTIDE BOTULINUM TOXIN TYPE A vs BRENTUXIMAB BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN BOTULINUM TOXIN TYPE A vs BREO ELLIPTA BOTULINUM TOXIN TYPE A vs BREXANOLONE

Related Pages

BOTULINUM TOXIN TYPE A Full Profile All Gait disturbance Reports All Drugs Causing Gait disturbance BOTULINUM TOXIN TYPE A Demographics